4.3 Article

Manic/Hypomanic Symptom Burden and Cardiovascular Mortality in Bipolar Disorder

期刊

PSYCHOSOMATIC MEDICINE
卷 71, 期 6, 页码 598-606

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/PSY.0b013e3181acee26

关键词

adult; bipolar disorder; cardiovascular mortality; mania; prospective cohort study; risk factors

资金

  1. National Institute of Mental Health [5R01MH025416, 5R01MH023864, 5R01MH025478, 5R01MH025430, 5R01MH029957]
  2. Nellie Ball Trust Research Fund
  3. NARSAD Young Investigator Awar
  4. Janserm Pharmaceutica
  5. Abbott
  6. Bristol-Meyers
  7. Cyberonics
  8. Intemeuron
  9. Merck
  10. Parkc-Davis
  11. Pfizer
  12. UpJohn
  13. Wyeth-Ayerst
  14. [L30 MH075180]

向作者/读者索取更多资源

Objectives: To compare the risk for cardiovascular mortality between bipolar I and bipolar II subtypes and determine correlates of cardiovascular mortality. Bipolar disorder conveys an increased risk of cardiovascular mortality. Methods: Participants with major affective disorders were recruited for the National Institute of Mental Health Collaborative Depression Study and followed prospectively for up to 25 years. A total of 435 participants met the diagnostic criteria for bipolar I (n = 288) or bipolar II (n = 147) disorder based on Research Diagnostic Criteria at intake and measures of psychiatric symptoms during follow-up. Diagnostic subtypes were contrasted by cardiovascular mortality risk using Cox proportional hazards regression. Affective symptom burden (the proportion of time with clinically significant manic/hypomanic or depressive symptoms) and treatment exposure were additionally included in the models. Results: Thirty-three participants died from cardiovascular causes. Participants with bipolar I disorder had more than double the cardiovascular mortality risk of those with bipolar It disorder, after controlling for age and gender (hazard ratio = 2.35, 95% Confidence Interval = 1.04-5.33; p = .04). The observed difference in cardiovascular mortality between these subtypes was at least partially confounded by the burden of clinically significant manic/hypomanic symptoms which predicted cardiovascular mortality independent of diagnosis, treatment exposure, age, gender, and cardiovascular risk factors at intake. Selective serotonin uptake inhibitors seemed protective although they were introduced late in follow-up. Depressive symptom burden was not related to cardiovascular mortality. Conclusions: Participants with bipolar I disorder may face a greater risk of cardiovascular mortality than those with bipolar II disorder. This difference in cardiovascular mortality risk may reflect manic/hypomanic symptom burden.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据